Home › Funds › 5AM Venture Management, LLC › SLN
5AM Venture Management, LLC position in SLN
SILENCE THERAPEUTICS PLC · Health Care
5AM Venture Management, LLC reported holding 476,200 shares of SLN (SILENCE THERAPEUTICS PLC) in its Q2 2026 13F filing — a position valued at US$5.2M, representing 1.82% of its reported portfolio and ranking #16 among its reported holdings. 5AM Venture Management, LLC has disclosed SLN holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How 5AM Venture Management, LLC's SLN position evolved
5AM Venture Management, LLC first disclosed a stake in SLN in Q1 2024 at 476,200 shares (US$10.3M). Across 10 filings, 5AM Venture Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 476,200 shares valued at US$5.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 476.20K | $10.29M | New |
| Q2 2024 | 476.20K | $9.05M | Hold |
| Q3 2024 | 476.20K | $8.66M | Hold |
| Q4 2024 | 476.20K | $3.28M | Hold |
| Q1 2025 | 476.20K | $1.34M | Hold |
| Q2 2025 | 476.20K | $2.76M | Hold |
| Q3 2025 | 476.20K | $2.47M | Hold |
| Q4 2025 | 476.20K | $2.90M | Hold |
| Q1 2026 | 476.20K | $2.51M | Hold |
| Q2 2026 | 476.20K | $5.23M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLN and 13F data
SLN (SILENCE THERAPEUTICS PLC) is a Health Care company. 35 other funds we track also report a position in SLN — the largest reported positions include Siren, L.L.C. (US$36.4M), TCG Crossover Management, LLC (US$33.3M), Redmile Group, LLC (US$23.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLN
- Siren, L.L.C. 3.31M sh · $36.36M · Q2 2026
- TCG Crossover Management, LLC 3.03M sh · $33.31M · Q2 2026
- Redmile Group, LLC 2.16M sh · $23.77M · Q2 2026
- Nantahala Capital Management, LLC 1.35M sh · $14.79M · Q2 2026
- Nextech Invest Ltd. 952.40K sh · $10.46M · Q2 2026
- GREAT POINT PARTNERS LLC 450.00K sh · $4.94M · Q2 2026
- Tetragon Partners GP Ltd 300.00K sh · $3.29M · Q2 2026
- Ishara Investments LP 55.35K sh · $2.43M · Q2 2026
- Propel Bio Management, LLC 191.73K sh · $2.11M · Q2 2026
- M28 Capital Management LP 101.20K sh · $1.11M · Q2 2026
More on 5AM Venture Management, LLC
FAQ
How long has 5AM Venture Management, LLC held SLN?
5AM Venture Management, LLC has disclosed SLN holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is 5AM Venture Management, LLC's current position in SLN?
As of Q2 2026, 5AM Venture Management, LLC holds 476.20K shares of SLN (SILENCE THERAPEUTICS PLC), valued at $5.23M, representing 1.82% of its reported portfolio and ranking #16.
Has 5AM Venture Management, LLC been buying or selling SLN?
In the latest 13F filing (Q2 2026), 5AM Venture Management, LLC held unchanged its position in SLN.
Which other funds hold SLN?
Other major institutional holders of SLN include Siren, L.L.C., TCG Crossover Management, LLC, Redmile Group, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.